Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029901 | SCV000052556 | pathogenic | Maturity-onset diabetes of the young type 2 | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Pathogenic. |
Gene |
RCV000421286 | SCV000515865 | pathogenic | not provided | 2015-03-05 | criteria provided, single submitter | clinical testing | The Y215X nonsense variant in the GCK gene has been reported previously in association with MODY2(Sagen et al., 2008). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Y215X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret Y215X as a pathogenic variant. |
Athena Diagnostics | RCV000421286 | SCV005620890 | pathogenic | not provided | 2024-01-05 | criteria provided, single submitter | clinical testing | This variant is expected to result in the loss of a functional protein. This variant has been identified in multiple unrelated individuals with MODY. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) |